Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Campbell McInnes

7PUBLICATIONS
5CO-AUTHORS
Molecular targetsGene and molecular therapyBasic pharmacologyCheminformatics and quantitative structure-activity relationshipsClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|May 16, 2025
Structural regulation of PLK1 activity: implications for cell cycle function and drug discovery.

Danda Chapagai, Klaus Strebhardt, Michael D Wyatt

|Dec 12, 2024
Overcoming Resistance to FLT3-ITD Therapeutics.

Campbell McInnes

|Jul 11, 2023
Structural Basis for Variations in Polo-like Kinase 1 Conformation and Intracellular Stability Induced by ATP-Competitive and Novel Noncompetitive Abbapolin Inhibitors.

Danda Chapagai, George Merhej, Campbell McInnes

|Feb 03, 2022
A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics.

Li Zhang, Chen Cheng, Jing Li

|Jul 02, 2021
Nonpeptidic, Polo-Box Domain-Targeted Inhibitors of PLK1 Block Kinase Activity, Induce Its Degradation and Target-Resistant Cells.

Danda Chapagai, Gurusankar Ramamoorthy, Jessy Varghese

|Apr 02, 2020
Peptidomimetic Polo-Box-Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor.

Merissa Baxter, Danda Chapagai, Sandra Craig

Pageof 2

Frequent Collaborators

4 joint publications

Michael D Wyatt

3 joint publications

Danda Chapagai

1 joint publications

Igor B Roninson

1 joint publications

Mengqian Chen

1 joint publications

Klaus Strebhardt

Frequent Collaborators

4 joint publications

Michael D Wyatt

3 joint publications

Danda Chapagai

1 joint publications

Igor B Roninson

1 joint publications

Mengqian Chen

Top Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on : Apr 03, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on : Jan 07, 2019

8.2K
Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on : Jun 30, 2019

6.3K
See more related videos

Top Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on : Apr 03, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on : Jan 07, 2019

8.2K
Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on : Jun 30, 2019

6.3K
See more related videos